Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 5,561 | 4,349 | 5,604 | 4,015 | 3,754 |
| Cost of Goods | 3,380 | 2,699 | 3,484 | 2,551 | 2,226 |
| Gross Profit | 2,181 | 1,650 | 2,120 | 1,464 | 1,528 |
| Operating Expenses | 2,912 | 3,027 | 2,941 | 3,110 | 2,410 |
| Operating Income | -351 | -678 | -337 | -1,095 | -656 |
| Other Income | -146 | -271 | -394 | -147 | 128 |
| Pre-tax Income | -497 | -949 | -731 | -1,242 | -528 |
| Income Tax | 84 | -130 | -197 | -1 | 248 |
| Net Income Continuous | -581 | -819 | -534 | -1,241 | -776 |
| Net Income | $-581 | $-819 | $-534 | $-1,241 | $-776 |
| EPS Basic Total Ops | -0.33 | -0.48 | -0.32 | -0.76 | -0.23 |
| EPS Basic Continuous Ops | -0.33 | -0.48 | -0.32 | -0.76 | -0.22 |
| EPS Diluted Total Ops | -0.33 | -0.48 | -0.32 | -0.76 | -0.23 |
| EPS Diluted Continuous Ops | -0.33 | -0.48 | -0.32 | -0.76 | -0.22 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.35 | -0.13 | -0.37 | -0.15 |
| EBITDA(a) | $-318 | $-644 | $-301 | $-1,059 | $-625 |